79C3C34C52B45572883A05D425EB0F82
Commissioner's Directive- Research (DC009)
https://www.csc-scc.gc.ca/politiques-et-lois/009-cd-en.shtml
http://leaux.net/URLS/ConvertAPI Text Files/BDFADAE91BC734B158A2BBA194AC0881.en.txt
Examining the file media/Synopses/BDFADAE91BC734B158A2BBA194AC0881.html:
This file was generated: 2020-12-01 05:28:38
Indicators in focus are typically shown highlighted in yellow; |
Peer Indicators (that share the same Vulnerability association) are shown highlighted in pink; |
"Outside" Indicators (those that do NOT share the same Vulnerability association) are shown highlighted in green; |
Trigger Words/Phrases are shown highlighted in gray. |
Link to Orphaned Trigger Words (Appendix (Indicator List, Indicator Peers, Trigger Words, Type/Vulnerability/Indicator Overlay)
Applicable Type / Vulnerability / Indicator Overlay for this Input
Health / Healthy People
Searching for indicator volunteers:
(return to top)
p.(None):
p.(None): Correctional Service Canada
p.(None): Acts and Commissioner's
p.(None):
p.(None): Home Regulations Directives Research
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): Commissioner's Directives 009
p.(None): Research
p.(None): Commissioner's Directives
p.(None):
p.(None): Number: 009
p.(None):
p.(None): In Effect: 2017-11-20
p.(None):
p.(None): Related links:
p.(None): Policy Bulletin 579
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): Authorities
p.(None): Corrections and Conditional Release Act (CCRA), sections 3, 4, 5 and 88
p.(None): Corrections and Conditional Release Regulations (CCRR), section 115
p.(None): Privacy Act, paragraph 8(2)(j)
p.(None): Copyright Act
p.(None): Access to Information Act, sections 18, 21 and 22
p.(None):
p.(None):
p.(None):
p.(None): Purpose
p.(None): To ensure that all CSC-related research meets legal, ethical, methodological and scientific standards
p.(None):
p.(None):
p.(None):
p.(None): Application
p.(None): Applies to all researchers, including CSC staff, students, volunteers and contractors
p.(None):
p.(None):
p.(None):
p.(None): Contents
p.(None): Responsibilities
p.(None): Procedures
p.(None): Employee Opinion Survey
p.(None): Compensation for Participation
p.(None): Medical Research and Experimental Treatment
p.(None): Informed Consent
p.(None): Submission of Research Proposals
p.(None): Approval of Research Proposals
p.(None): Personal Information
p.(None): Publication and Copyright
p.(None): Annex A - Cross-References and Definitions
p.(None): Annex B - Research Governance
p.(None):
p.(None):
p.(None):
p.(None): Responsibilities
p.(None): 1. The Executive Committee (EXCOM) of the Correctional Service of Canada (CSC) is responsible for approving the Annual Research Plan.
p.(None):
p.(None): 2. The EXCOM Sub-Committee for External Research will review and approve external research proposals based on recommendations provided by
p.(None): the National Headquarters (NHQ) External Research Review Committee and assess the anticipated benefits and relevance of the proposed
p.(None): research for CSC.
p.(None):
p.(None): 3. The NHQ External Research Review Committee will:
p.(None):
p.(None): a. review and assess research proposals and make recommendations to the EXCOM Sub-Committee for External Research
p.(None):
p.(None): b. consult with relevant NHQ sectors and regions implicated in proposed research as well as other departments and agencies that may be
p.(None): involved.
p.(None):
p.(None): 4. The Director, Research, will:
p.(None): a. coordinate the development and implementation of the Annual Research Plan and ensure its integrity
p.(None):
p.(None): b. establish a process to review research proposals (see Annex B), as required
p.(None):
p.(None): c. coordinate the dissemination of research results.
p.(None):
...
Health / Motherhood/Family
Searching for indicator family:
(return to top)
p.(None): submit them to NHQ Research Branch for review and approval.
p.(None):
p.(None): 18. Researchers affiliated with a university (including students and university staff) must obtain approval for proposed research projects from their
p.(None): respective university ethics committees prior to submitting a proposal to NHQ Research Branch. This review must be completed in compliance with
p.(None): the Tri-Council Policy Statement on Ethical Conduct for Research Involving Humans.
p.(None):
p.(None):
p.(None): Approval of Research Proposals
p.(None): 19. Research proposals will be assessed according to the following criteria:
p.(None): a. conformity with the principles of the CCRA and the Privacy Act
p.(None):
p.(None): b. contribution to the achievement of the Mission and the priorities of CSC
p.(None):
p.(None): c. compliance with the Tri-Council Policy Statement on Ethical Conduct for Research Involving Humans, including respect of the framework on
p.(None): ethical conduct of Research Involving the First Nations, Inuit and Métis Peoples of Canada
p.(None):
p.(None): d. level of disruption to operational units, including operational resources required during data collection
p.(None):
p.(None): e. quality of the methodology
p.(None):
p.(None): f. qualifications of researchers
p.(None):
p.(None): g. anticipated benefit to CSC
p.(None):
p.(None): h. level of risk, including but not limited to consideration of security threat risks, risks to the research team, offender and their family, staff,
p.(None): institution, victims etc.
p.(None):
p.(None): 20. Approval to conduct research is effective the date the study is approved by CSC and will remain valid for a two year period following this date.
p.(None): Following this two year period, the researcher must request an extension or submit a new proposal.
p.(None):
p.(None): 21. Approval to conduct research may be temporarily suspended for operational reasons or may be withdrawn at any time for violations of standing
p.(None): orders, violations of rules and regulations related to security, and/or for unapproved deviations from the original proposal.
p.(None):
p.(None): 22. Data collected during a research study may only be used for the purposes outlined in the proposal; all subsequent or additional research questions
p.(None): must be submitted through the research proposal review and approval process.
p.(None):
p.(None):
p.(None): Personal Information
p.(None): 23. Researchers must obtain appropriate security clearance, in accordance with CD 564-1 – Individual Security Screening prior to receiving access to
p.(None): protected or personal identifying information.
p.(None):
p.(None): 24. Personal identifying information shall only be given to researchers if one of the two following conditions is met:
p.(None):
p.(None): a. consent for disclosure from each participant is obtained
p.(None):
p.(None): b. the Commissioner determines that the information can be disclosed based upon the provisions of paragraph 8(2)(j) of the Privacy Act.
p.(None):
...
Health / Physically Disabled
Searching for indicator illness:
(return to top)
p.(None): GL 800-3 – Consent to Health Service Assessment, Treatment and Release of Information
p.(None):
p.(None): Tri-Council Policy Statement on Ethical Conduct for Research Involving Humans
p.(None): Communications Policy of the Government of Canada
p.(None):
p.(None):
p.(None):
p.(None): Definitions
p.(None): EXCOM Sub-Committee for External Research: a committee comprised of the Senior Deputy Commissioner, the Assistant Commissioner, Policy, and
p.(None): the Director, Research Branch.
p.(None):
p.(None): NHQ External Research Review Committee: a committee comprised of the Director, Research Branch, Senior Research Managers, and
p.(None): representatives from the Correctional Operations and Programs Sector, Health Services, Women Offender Sector, and the Aboriginal Initiatives
p.(None): Directorate.
p.(None):
p.(None): Research: the systematic collection and use of data or the controlled investigation into a subject to provide an organized body of knowledge. The
p.(None): collection and/or analysis of CSC data that is required for administrative, operational or organizational purposes is not considered research. The objective
p.(None): of a research activity is to contribute to generalizable knowledge in the area of focus with the intent to share, distribute and/or disseminate findings when
p.(None): appropriate.
p.(None):
p.(None): Special Access Program: a program managed by Health Canada that has the mandate of making drugs that are not approved for use in Canada
p.(None): available on application by a practitioner. These drugs are used to treat patients with a serious or life-threatening illness when conventional therapies
p.(None): have failed or are unsuitable and may include pharmaceuticals, biological and radiopharmaceutical products.
p.(None):
p.(None): Treatment Demonstration Program: a clinical trial or pharmaceutical treatment that is not approved for general use in Canada. Such a program is
p.(None): characterized by the use of a scientifically designed experiment in which control groups, randomization and placebos may be present. It may also include
p.(None): drugs obtained under the Special Access Program of Health Canada.
p.(None):
p.(None):
p.(None):
p.(None): Annex B
p.(None): Research Governance
p.(None): Date modified: 2017-11-17
...
Social / Access to Social Goods
Searching for indicator access:
(return to top)
p.(None): Annex B - Research Governance
p.(None):
p.(None):
p.(None):
p.(None): Responsibilities
p.(None): 1. The Executive Committee (EXCOM) of the Correctional Service of Canada (CSC) is responsible for approving the Annual Research Plan.
p.(None):
p.(None): 2. The EXCOM Sub-Committee for External Research will review and approve external research proposals based on recommendations provided by
p.(None): the National Headquarters (NHQ) External Research Review Committee and assess the anticipated benefits and relevance of the proposed
p.(None): research for CSC.
p.(None):
p.(None): 3. The NHQ External Research Review Committee will:
p.(None):
p.(None): a. review and assess research proposals and make recommendations to the EXCOM Sub-Committee for External Research
p.(None):
p.(None): b. consult with relevant NHQ sectors and regions implicated in proposed research as well as other departments and agencies that may be
p.(None): involved.
p.(None):
p.(None): 4. The Director, Research, will:
p.(None): a. coordinate the development and implementation of the Annual Research Plan and ensure its integrity
p.(None):
p.(None): b. establish a process to review research proposals (see Annex B), as required
p.(None):
p.(None): c. coordinate the dissemination of research results.
p.(None):
p.(None): 5. The regional research representatives will:
p.(None):
p.(None): a. review research proposals implicating their region
p.(None):
p.(None): b. share information and consult with implicated parties within the region, including the institutions, community residential facilities, and parole
p.(None): offices
p.(None):
p.(None): c. assess the feasibility of projects and give consideration to operational impacts and resource requirements.
p.(None):
p.(None): 6. The sites implicated will facilitate the researchers’ access to CSC facilities and provide support as outlined in the approved research proposal.
p.(None):
p.(None):
p.(None):
p.(None): Procedures
p.(None):
p.(None): Employee Opinion Survey
p.(None): 7. Employee opinion surveys may be considered public opinion research and are subject to the Policy on Communications and Federal Identity.
p.(None):
p.(None):
p.(None): Compensation for Participation
p.(None): 8. Inmates participating in research projects will not be compensated. Where participation requires an absence from a program assignment, those
p.(None): hours will be calculated as worked hours.
p.(None):
p.(None): 9. The NHQ External Research Review Committee will review and approve the provision of reasonable compensation for CSC employees and/or
p.(None): offenders under supervision participating in research project in the community.
p.(None):
p.(None):
p.(None): Medical Research and Experimental Treatment
p.(None): 10. Health-related research for external publication or dissemination is subject to the review and approval process outlined in this policy document.
p.(None):
p.(None): 11. There will be no experimental treatment unless it meets the necessary requirements of subsection 88(4) of the CCRA and section 115 of the CCRR,
p.(None): that provide for a review by a Treatment Demonstration Program Committee that is independent of CSC.
p.(None):
p.(None): 12. In accordance with section 115 of the CCRR, the Treatment Demonstration Program Committee shall be comprised of equal numbers from the
p.(None): community of lay persons and registered health care professionals with expertise related to the treatment demonstration program.
p.(None):
...
p.(None): ethical conduct of Research Involving the First Nations, Inuit and Métis Peoples of Canada
p.(None):
p.(None): d. level of disruption to operational units, including operational resources required during data collection
p.(None):
p.(None): e. quality of the methodology
p.(None):
p.(None): f. qualifications of researchers
p.(None):
p.(None): g. anticipated benefit to CSC
p.(None):
p.(None): h. level of risk, including but not limited to consideration of security threat risks, risks to the research team, offender and their family, staff,
p.(None): institution, victims etc.
p.(None):
p.(None): 20. Approval to conduct research is effective the date the study is approved by CSC and will remain valid for a two year period following this date.
p.(None): Following this two year period, the researcher must request an extension or submit a new proposal.
p.(None):
p.(None): 21. Approval to conduct research may be temporarily suspended for operational reasons or may be withdrawn at any time for violations of standing
p.(None): orders, violations of rules and regulations related to security, and/or for unapproved deviations from the original proposal.
p.(None):
p.(None): 22. Data collected during a research study may only be used for the purposes outlined in the proposal; all subsequent or additional research questions
p.(None): must be submitted through the research proposal review and approval process.
p.(None):
p.(None):
p.(None): Personal Information
p.(None): 23. Researchers must obtain appropriate security clearance, in accordance with CD 564-1 – Individual Security Screening prior to receiving access to
p.(None): protected or personal identifying information.
p.(None):
p.(None): 24. Personal identifying information shall only be given to researchers if one of the two following conditions is met:
p.(None):
p.(None): a. consent for disclosure from each participant is obtained
p.(None):
p.(None): b. the Commissioner determines that the information can be disclosed based upon the provisions of paragraph 8(2)(j) of the Privacy Act.
p.(None):
p.(None): 25. The Privacy Act provides the Research Branch the authority to access personal information and use administrative data without obtaining consent
p.(None): when it is to be used “for the purpose for which the information was obtained or compiled or for a use consistent with that purpose” (paragraph 7(a)),
p.(None): or “for research or statistical purposes if the head of government” is satisfied that subparagraphs 8(2)(j)(i) and/or (ii) are met.
p.(None):
p.(None): 26. There will be no subsequent disclosure of personal identifying information unless the participants have provided their consent or the information has
p.(None): been depersonalized in accordance with the undertaking given by the researcher under paragraph 8(2)(j) of the Privacy Act.
p.(None):
p.(None): 27. In the exceptional circumstance where the use of personal identifiers was unavoidable, the research will be reviewed and vetted by the NHQ
p.(None): Access to Information and Privacy Division
p.(None):
p.(None):
p.(None): Publication and Copyright
p.(None): 28. As per the Copyright Act, Her Majesty the Queen in Right of Canada, as represented by the Minister of Public Safety and Emergency
p.(None): Preparedness, is the owner of all intellectual property rights to the work prepared by CSC employees. This applies to all research conducted by
p.(None): employees as part of their official role and responsibilities.
p.(None):
...
p.(None):
p.(None):
p.(None): Commissioner,
p.(None):
p.(None):
p.(None):
p.(None): Original signed by:
p.(None): Don Head
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): Annex A
p.(None): Cross-References
p.(None): CD 564-1 – Individual Security Screening
p.(None): GL 800-3 – Consent to Health Service Assessment, Treatment and Release of Information
p.(None):
p.(None): Tri-Council Policy Statement on Ethical Conduct for Research Involving Humans
p.(None): Communications Policy of the Government of Canada
p.(None):
p.(None):
p.(None):
p.(None): Definitions
p.(None): EXCOM Sub-Committee for External Research: a committee comprised of the Senior Deputy Commissioner, the Assistant Commissioner, Policy, and
p.(None): the Director, Research Branch.
p.(None):
p.(None): NHQ External Research Review Committee: a committee comprised of the Director, Research Branch, Senior Research Managers, and
p.(None): representatives from the Correctional Operations and Programs Sector, Health Services, Women Offender Sector, and the Aboriginal Initiatives
p.(None): Directorate.
p.(None):
p.(None): Research: the systematic collection and use of data or the controlled investigation into a subject to provide an organized body of knowledge. The
p.(None): collection and/or analysis of CSC data that is required for administrative, operational or organizational purposes is not considered research. The objective
p.(None): of a research activity is to contribute to generalizable knowledge in the area of focus with the intent to share, distribute and/or disseminate findings when
p.(None): appropriate.
p.(None):
p.(None): Special Access Program: a program managed by Health Canada that has the mandate of making drugs that are not approved for use in Canada
p.(None): available on application by a practitioner. These drugs are used to treat patients with a serious or life-threatening illness when conventional therapies
p.(None): have failed or are unsuitable and may include pharmaceuticals, biological and radiopharmaceutical products.
p.(None):
p.(None): Treatment Demonstration Program: a clinical trial or pharmaceutical treatment that is not approved for general use in Canada. Such a program is
p.(None): characterized by the use of a scientifically designed experiment in which control groups, randomization and placebos may be present. It may also include
p.(None): drugs obtained under the Special Access Program of Health Canada.
p.(None):
p.(None):
p.(None):
p.(None): Annex B
p.(None): Research Governance
p.(None): Date modified: 2017-11-17
...
Searching for indicator accessXtoXinformation:
(return to top)
p.(None):
p.(None): Correctional Service Canada
p.(None): Acts and Commissioner's
p.(None):
p.(None): Home Regulations Directives Research
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): Commissioner's Directives 009
p.(None): Research
p.(None): Commissioner's Directives
p.(None):
p.(None): Number: 009
p.(None):
p.(None): In Effect: 2017-11-20
p.(None):
p.(None): Related links:
p.(None): Policy Bulletin 579
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): Authorities
p.(None): Corrections and Conditional Release Act (CCRA), sections 3, 4, 5 and 88
p.(None): Corrections and Conditional Release Regulations (CCRR), section 115
p.(None): Privacy Act, paragraph 8(2)(j)
p.(None): Copyright Act
p.(None): Access to Information Act, sections 18, 21 and 22
p.(None):
p.(None):
p.(None):
p.(None): Purpose
p.(None): To ensure that all CSC-related research meets legal, ethical, methodological and scientific standards
p.(None):
p.(None):
p.(None):
p.(None): Application
p.(None): Applies to all researchers, including CSC staff, students, volunteers and contractors
p.(None):
p.(None):
p.(None):
p.(None): Contents
p.(None): Responsibilities
p.(None): Procedures
p.(None): Employee Opinion Survey
p.(None): Compensation for Participation
p.(None): Medical Research and Experimental Treatment
p.(None): Informed Consent
p.(None): Submission of Research Proposals
p.(None): Approval of Research Proposals
p.(None): Personal Information
p.(None): Publication and Copyright
p.(None): Annex A - Cross-References and Definitions
p.(None): Annex B - Research Governance
p.(None):
p.(None):
p.(None):
p.(None): Responsibilities
p.(None): 1. The Executive Committee (EXCOM) of the Correctional Service of Canada (CSC) is responsible for approving the Annual Research Plan.
p.(None):
p.(None): 2. The EXCOM Sub-Committee for External Research will review and approve external research proposals based on recommendations provided by
p.(None): the National Headquarters (NHQ) External Research Review Committee and assess the anticipated benefits and relevance of the proposed
p.(None): research for CSC.
p.(None):
p.(None): 3. The NHQ External Research Review Committee will:
p.(None):
p.(None): a. review and assess research proposals and make recommendations to the EXCOM Sub-Committee for External Research
p.(None):
p.(None): b. consult with relevant NHQ sectors and regions implicated in proposed research as well as other departments and agencies that may be
...
p.(None): 23. Researchers must obtain appropriate security clearance, in accordance with CD 564-1 – Individual Security Screening prior to receiving access to
p.(None): protected or personal identifying information.
p.(None):
p.(None): 24. Personal identifying information shall only be given to researchers if one of the two following conditions is met:
p.(None):
p.(None): a. consent for disclosure from each participant is obtained
p.(None):
p.(None): b. the Commissioner determines that the information can be disclosed based upon the provisions of paragraph 8(2)(j) of the Privacy Act.
p.(None):
p.(None): 25. The Privacy Act provides the Research Branch the authority to access personal information and use administrative data without obtaining consent
p.(None): when it is to be used “for the purpose for which the information was obtained or compiled or for a use consistent with that purpose” (paragraph 7(a)),
p.(None): or “for research or statistical purposes if the head of government” is satisfied that subparagraphs 8(2)(j)(i) and/or (ii) are met.
p.(None):
p.(None): 26. There will be no subsequent disclosure of personal identifying information unless the participants have provided their consent or the information has
p.(None): been depersonalized in accordance with the undertaking given by the researcher under paragraph 8(2)(j) of the Privacy Act.
p.(None):
p.(None): 27. In the exceptional circumstance where the use of personal identifiers was unavoidable, the research will be reviewed and vetted by the NHQ
p.(None): Access to Information and Privacy Division
p.(None):
p.(None):
p.(None): Publication and Copyright
p.(None): 28. As per the Copyright Act, Her Majesty the Queen in Right of Canada, as represented by the Minister of Public Safety and Emergency
p.(None): Preparedness, is the owner of all intellectual property rights to the work prepared by CSC employees. This applies to all research conducted by
p.(None): employees as part of their official role and responsibilities.
p.(None):
p.(None): 29. In the case of research conducted without direction or control from CSC, the primary researcher owns the intellectual property rights to any thesis,
p.(None): journal articles, conference papers, or other written reports incorporating the results of a study approved by CSC. Any and all rights to materials
p.(None): and data used and provided by the primary researcher are the property of the primary researcher. Any and all rights to materials and data provided
p.(None): by CSC to the primary researcher are the property of CSC and will be returned to CSC at the end of the study.
p.(None):
p.(None): 30. In the case of research conducted under contract or otherwise sponsored by CSC (Memoranda of Understanding, Memoranda of Agreements, sole
p.(None): source contracts, etc.), the written undertaking must identify ownership of intellectual property and specify that all data is to be returned to CSC.
p.(None):
...
Social / Property Ownership
Searching for indicator property:
(return to top)
p.(None):
p.(None): a. consent for disclosure from each participant is obtained
p.(None):
p.(None): b. the Commissioner determines that the information can be disclosed based upon the provisions of paragraph 8(2)(j) of the Privacy Act.
p.(None):
p.(None): 25. The Privacy Act provides the Research Branch the authority to access personal information and use administrative data without obtaining consent
p.(None): when it is to be used “for the purpose for which the information was obtained or compiled or for a use consistent with that purpose” (paragraph 7(a)),
p.(None): or “for research or statistical purposes if the head of government” is satisfied that subparagraphs 8(2)(j)(i) and/or (ii) are met.
p.(None):
p.(None): 26. There will be no subsequent disclosure of personal identifying information unless the participants have provided their consent or the information has
p.(None): been depersonalized in accordance with the undertaking given by the researcher under paragraph 8(2)(j) of the Privacy Act.
p.(None):
p.(None): 27. In the exceptional circumstance where the use of personal identifiers was unavoidable, the research will be reviewed and vetted by the NHQ
p.(None): Access to Information and Privacy Division
p.(None):
p.(None):
p.(None): Publication and Copyright
p.(None): 28. As per the Copyright Act, Her Majesty the Queen in Right of Canada, as represented by the Minister of Public Safety and Emergency
p.(None): Preparedness, is the owner of all intellectual property rights to the work prepared by CSC employees. This applies to all research conducted by
p.(None): employees as part of their official role and responsibilities.
p.(None):
p.(None): 29. In the case of research conducted without direction or control from CSC, the primary researcher owns the intellectual property rights to any thesis,
p.(None): journal articles, conference papers, or other written reports incorporating the results of a study approved by CSC. Any and all rights to materials
p.(None): and data used and provided by the primary researcher are the property of the primary researcher. Any and all rights to materials and data provided
p.(None): by CSC to the primary researcher are the property of CSC and will be returned to CSC at the end of the study.
p.(None):
p.(None): 30. In the case of research conducted under contract or otherwise sponsored by CSC (Memoranda of Understanding, Memoranda of Agreements, sole
p.(None): source contracts, etc.), the written undertaking must identify ownership of intellectual property and specify that all data is to be returned to CSC.
p.(None):
p.(None): 31. Copies of all reports resulting from approved research conducted by contractors, external researchers, or CSC employees shall be forwarded to the
p.(None): NHQ Research Branch for information purposes. Sufficient time (at least six weeks) must be given for their review in advance of any release,
p.(None): publication, presentation or other research dissemination.
p.(None):
p.(None): 32. Any research conducted by CSC employees and/or the use of an employee’s CSC affiliation in reporting independent research, including projects
p.(None): approved by the EXCOM Sub-Committee for External Research, must be submitted to the appropriate sector/regional heads for information
p.(None): purposes prior to external distribution. This includes but is not limited to publication in academic journals, conference presentations, book chapters,
p.(None): etc.
p.(None):
p.(None): 33. In the case of research conducted under contract or otherwise sponsored by the CSC Research Branch, sharing of research findings will be
p.(None): managed by the Director, Research.
p.(None):
p.(None): 34. Researchers will make appropriate acknowledgement in all reports of CSC’s sponsorship of the research, as well as an appropriate disclaimer that
p.(None): the opinions and conclusions do not necessarily represent those of the Service and/or Public Safety Canada.
p.(None):
p.(None):
p.(None): Commissioner,
p.(None):
p.(None):
p.(None):
p.(None): Original signed by:
p.(None): Don Head
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): Annex A
p.(None): Cross-References
p.(None): CD 564-1 – Individual Security Screening
...
Social / Threat of Stigma
Searching for indicator threat:
(return to top)
p.(None):
p.(None): Submission of Research Proposals
p.(None): 17. Researchers must complete the Research Application and Undertaking form (CSC/SCC 0954e) and supporting documents, where required, and
p.(None): submit them to NHQ Research Branch for review and approval.
p.(None):
p.(None): 18. Researchers affiliated with a university (including students and university staff) must obtain approval for proposed research projects from their
p.(None): respective university ethics committees prior to submitting a proposal to NHQ Research Branch. This review must be completed in compliance with
p.(None): the Tri-Council Policy Statement on Ethical Conduct for Research Involving Humans.
p.(None):
p.(None):
p.(None): Approval of Research Proposals
p.(None): 19. Research proposals will be assessed according to the following criteria:
p.(None): a. conformity with the principles of the CCRA and the Privacy Act
p.(None):
p.(None): b. contribution to the achievement of the Mission and the priorities of CSC
p.(None):
p.(None): c. compliance with the Tri-Council Policy Statement on Ethical Conduct for Research Involving Humans, including respect of the framework on
p.(None): ethical conduct of Research Involving the First Nations, Inuit and Métis Peoples of Canada
p.(None):
p.(None): d. level of disruption to operational units, including operational resources required during data collection
p.(None):
p.(None): e. quality of the methodology
p.(None):
p.(None): f. qualifications of researchers
p.(None):
p.(None): g. anticipated benefit to CSC
p.(None):
p.(None): h. level of risk, including but not limited to consideration of security threat risks, risks to the research team, offender and their family, staff,
p.(None): institution, victims etc.
p.(None):
p.(None): 20. Approval to conduct research is effective the date the study is approved by CSC and will remain valid for a two year period following this date.
p.(None): Following this two year period, the researcher must request an extension or submit a new proposal.
p.(None):
p.(None): 21. Approval to conduct research may be temporarily suspended for operational reasons or may be withdrawn at any time for violations of standing
p.(None): orders, violations of rules and regulations related to security, and/or for unapproved deviations from the original proposal.
p.(None):
p.(None): 22. Data collected during a research study may only be used for the purposes outlined in the proposal; all subsequent or additional research questions
p.(None): must be submitted through the research proposal review and approval process.
p.(None):
p.(None):
p.(None): Personal Information
p.(None): 23. Researchers must obtain appropriate security clearance, in accordance with CD 564-1 – Individual Security Screening prior to receiving access to
p.(None): protected or personal identifying information.
p.(None):
p.(None): 24. Personal identifying information shall only be given to researchers if one of the two following conditions is met:
p.(None):
p.(None): a. consent for disclosure from each participant is obtained
p.(None):
p.(None): b. the Commissioner determines that the information can be disclosed based upon the provisions of paragraph 8(2)(j) of the Privacy Act.
p.(None):
...
Social / Women
Searching for indicator women:
(return to top)
p.(None): purposes prior to external distribution. This includes but is not limited to publication in academic journals, conference presentations, book chapters,
p.(None): etc.
p.(None):
p.(None): 33. In the case of research conducted under contract or otherwise sponsored by the CSC Research Branch, sharing of research findings will be
p.(None): managed by the Director, Research.
p.(None):
p.(None): 34. Researchers will make appropriate acknowledgement in all reports of CSC’s sponsorship of the research, as well as an appropriate disclaimer that
p.(None): the opinions and conclusions do not necessarily represent those of the Service and/or Public Safety Canada.
p.(None):
p.(None):
p.(None): Commissioner,
p.(None):
p.(None):
p.(None):
p.(None): Original signed by:
p.(None): Don Head
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): Annex A
p.(None): Cross-References
p.(None): CD 564-1 – Individual Security Screening
p.(None): GL 800-3 – Consent to Health Service Assessment, Treatment and Release of Information
p.(None):
p.(None): Tri-Council Policy Statement on Ethical Conduct for Research Involving Humans
p.(None): Communications Policy of the Government of Canada
p.(None):
p.(None):
p.(None):
p.(None): Definitions
p.(None): EXCOM Sub-Committee for External Research: a committee comprised of the Senior Deputy Commissioner, the Assistant Commissioner, Policy, and
p.(None): the Director, Research Branch.
p.(None):
p.(None): NHQ External Research Review Committee: a committee comprised of the Director, Research Branch, Senior Research Managers, and
p.(None): representatives from the Correctional Operations and Programs Sector, Health Services, Women Offender Sector, and the Aboriginal Initiatives
p.(None): Directorate.
p.(None):
p.(None): Research: the systematic collection and use of data or the controlled investigation into a subject to provide an organized body of knowledge. The
p.(None): collection and/or analysis of CSC data that is required for administrative, operational or organizational purposes is not considered research. The objective
p.(None): of a research activity is to contribute to generalizable knowledge in the area of focus with the intent to share, distribute and/or disseminate findings when
p.(None): appropriate.
p.(None):
p.(None): Special Access Program: a program managed by Health Canada that has the mandate of making drugs that are not approved for use in Canada
p.(None): available on application by a practitioner. These drugs are used to treat patients with a serious or life-threatening illness when conventional therapies
p.(None): have failed or are unsuitable and may include pharmaceuticals, biological and radiopharmaceutical products.
p.(None):
p.(None): Treatment Demonstration Program: a clinical trial or pharmaceutical treatment that is not approved for general use in Canada. Such a program is
p.(None): characterized by the use of a scientifically designed experiment in which control groups, randomization and placebos may be present. It may also include
p.(None): drugs obtained under the Special Access Program of Health Canada.
p.(None):
p.(None):
p.(None):
p.(None): Annex B
p.(None): Research Governance
p.(None): Date modified: 2017-11-17
...
Social / employees
Searching for indicator employees:
(return to top)
p.(None): involved.
p.(None):
p.(None): 4. The Director, Research, will:
p.(None): a. coordinate the development and implementation of the Annual Research Plan and ensure its integrity
p.(None):
p.(None): b. establish a process to review research proposals (see Annex B), as required
p.(None):
p.(None): c. coordinate the dissemination of research results.
p.(None):
p.(None): 5. The regional research representatives will:
p.(None):
p.(None): a. review research proposals implicating their region
p.(None):
p.(None): b. share information and consult with implicated parties within the region, including the institutions, community residential facilities, and parole
p.(None): offices
p.(None):
p.(None): c. assess the feasibility of projects and give consideration to operational impacts and resource requirements.
p.(None):
p.(None): 6. The sites implicated will facilitate the researchers’ access to CSC facilities and provide support as outlined in the approved research proposal.
p.(None):
p.(None):
p.(None):
p.(None): Procedures
p.(None):
p.(None): Employee Opinion Survey
p.(None): 7. Employee opinion surveys may be considered public opinion research and are subject to the Policy on Communications and Federal Identity.
p.(None):
p.(None):
p.(None): Compensation for Participation
p.(None): 8. Inmates participating in research projects will not be compensated. Where participation requires an absence from a program assignment, those
p.(None): hours will be calculated as worked hours.
p.(None):
p.(None): 9. The NHQ External Research Review Committee will review and approve the provision of reasonable compensation for CSC employees and/or
p.(None): offenders under supervision participating in research project in the community.
p.(None):
p.(None):
p.(None): Medical Research and Experimental Treatment
p.(None): 10. Health-related research for external publication or dissemination is subject to the review and approval process outlined in this policy document.
p.(None):
p.(None): 11. There will be no experimental treatment unless it meets the necessary requirements of subsection 88(4) of the CCRA and section 115 of the CCRR,
p.(None): that provide for a review by a Treatment Demonstration Program Committee that is independent of CSC.
p.(None):
p.(None): 12. In accordance with section 115 of the CCRR, the Treatment Demonstration Program Committee shall be comprised of equal numbers from the
p.(None): community of lay persons and registered health care professionals with expertise related to the treatment demonstration program.
p.(None):
p.(None): 13. An offender may volunteer to participate in a medical research study or a treatment demonstration program, for which an ethics review has taken
p.(None): place, only if they:
p.(None):
p.(None): a. have been diagnosed as having a condition which the study addresses
p.(None):
p.(None): b. understand the objective of the study and the anticipated benefits and risks in comparison with the current best treatment or no treatment, as
p.(None): outlined by health care professionals who are registered or licensed in Canada
p.(None):
p.(None): c. understand and accept the methods to be used, including the use of controls, placebos, and randomization
p.(None):
p.(None): d. have signed a consent form which clearly describes the objective of the study, the offender’s understanding of their involvement and the
...
p.(None):
p.(None): b. the Commissioner determines that the information can be disclosed based upon the provisions of paragraph 8(2)(j) of the Privacy Act.
p.(None):
p.(None): 25. The Privacy Act provides the Research Branch the authority to access personal information and use administrative data without obtaining consent
p.(None): when it is to be used “for the purpose for which the information was obtained or compiled or for a use consistent with that purpose” (paragraph 7(a)),
p.(None): or “for research or statistical purposes if the head of government” is satisfied that subparagraphs 8(2)(j)(i) and/or (ii) are met.
p.(None):
p.(None): 26. There will be no subsequent disclosure of personal identifying information unless the participants have provided their consent or the information has
p.(None): been depersonalized in accordance with the undertaking given by the researcher under paragraph 8(2)(j) of the Privacy Act.
p.(None):
p.(None): 27. In the exceptional circumstance where the use of personal identifiers was unavoidable, the research will be reviewed and vetted by the NHQ
p.(None): Access to Information and Privacy Division
p.(None):
p.(None):
p.(None): Publication and Copyright
p.(None): 28. As per the Copyright Act, Her Majesty the Queen in Right of Canada, as represented by the Minister of Public Safety and Emergency
p.(None): Preparedness, is the owner of all intellectual property rights to the work prepared by CSC employees. This applies to all research conducted by
p.(None): employees as part of their official role and responsibilities.
p.(None):
p.(None): 29. In the case of research conducted without direction or control from CSC, the primary researcher owns the intellectual property rights to any thesis,
p.(None): journal articles, conference papers, or other written reports incorporating the results of a study approved by CSC. Any and all rights to materials
p.(None): and data used and provided by the primary researcher are the property of the primary researcher. Any and all rights to materials and data provided
p.(None): by CSC to the primary researcher are the property of CSC and will be returned to CSC at the end of the study.
p.(None):
p.(None): 30. In the case of research conducted under contract or otherwise sponsored by CSC (Memoranda of Understanding, Memoranda of Agreements, sole
p.(None): source contracts, etc.), the written undertaking must identify ownership of intellectual property and specify that all data is to be returned to CSC.
p.(None):
p.(None): 31. Copies of all reports resulting from approved research conducted by contractors, external researchers, or CSC employees shall be forwarded to the
p.(None): NHQ Research Branch for information purposes. Sufficient time (at least six weeks) must be given for their review in advance of any release,
p.(None): publication, presentation or other research dissemination.
p.(None):
p.(None): 32. Any research conducted by CSC employees and/or the use of an employee’s CSC affiliation in reporting independent research, including projects
p.(None): approved by the EXCOM Sub-Committee for External Research, must be submitted to the appropriate sector/regional heads for information
p.(None): purposes prior to external distribution. This includes but is not limited to publication in academic journals, conference presentations, book chapters,
p.(None): etc.
p.(None):
p.(None): 33. In the case of research conducted under contract or otherwise sponsored by the CSC Research Branch, sharing of research findings will be
p.(None): managed by the Director, Research.
p.(None):
p.(None): 34. Researchers will make appropriate acknowledgement in all reports of CSC’s sponsorship of the research, as well as an appropriate disclaimer that
p.(None): the opinions and conclusions do not necessarily represent those of the Service and/or Public Safety Canada.
p.(None):
p.(None):
p.(None): Commissioner,
p.(None):
p.(None):
p.(None):
p.(None): Original signed by:
p.(None): Don Head
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): Annex A
p.(None): Cross-References
p.(None): CD 564-1 – Individual Security Screening
p.(None): GL 800-3 – Consent to Health Service Assessment, Treatment and Release of Information
p.(None):
p.(None): Tri-Council Policy Statement on Ethical Conduct for Research Involving Humans
p.(None): Communications Policy of the Government of Canada
p.(None):
p.(None):
p.(None):
p.(None): Definitions
p.(None): EXCOM Sub-Committee for External Research: a committee comprised of the Senior Deputy Commissioner, the Assistant Commissioner, Policy, and
p.(None): the Director, Research Branch.
p.(None):
...
Social / philosophical differences/differences of opinion
Searching for indicator opinion:
(return to top)
p.(None):
p.(None): Correctional Service Canada
p.(None): Acts and Commissioner's
p.(None):
p.(None): Home Regulations Directives Research
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): Commissioner's Directives 009
p.(None): Research
p.(None): Commissioner's Directives
p.(None):
p.(None): Number: 009
p.(None):
p.(None): In Effect: 2017-11-20
p.(None):
p.(None): Related links:
p.(None): Policy Bulletin 579
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): Authorities
p.(None): Corrections and Conditional Release Act (CCRA), sections 3, 4, 5 and 88
p.(None): Corrections and Conditional Release Regulations (CCRR), section 115
p.(None): Privacy Act, paragraph 8(2)(j)
p.(None): Copyright Act
p.(None): Access to Information Act, sections 18, 21 and 22
p.(None):
p.(None):
p.(None):
p.(None): Purpose
p.(None): To ensure that all CSC-related research meets legal, ethical, methodological and scientific standards
p.(None):
p.(None):
p.(None):
p.(None): Application
p.(None): Applies to all researchers, including CSC staff, students, volunteers and contractors
p.(None):
p.(None):
p.(None):
p.(None): Contents
p.(None): Responsibilities
p.(None): Procedures
p.(None): Employee Opinion Survey
p.(None): Compensation for Participation
p.(None): Medical Research and Experimental Treatment
p.(None): Informed Consent
p.(None): Submission of Research Proposals
p.(None): Approval of Research Proposals
p.(None): Personal Information
p.(None): Publication and Copyright
p.(None): Annex A - Cross-References and Definitions
p.(None): Annex B - Research Governance
p.(None):
p.(None):
p.(None):
p.(None): Responsibilities
p.(None): 1. The Executive Committee (EXCOM) of the Correctional Service of Canada (CSC) is responsible for approving the Annual Research Plan.
p.(None):
p.(None): 2. The EXCOM Sub-Committee for External Research will review and approve external research proposals based on recommendations provided by
p.(None): the National Headquarters (NHQ) External Research Review Committee and assess the anticipated benefits and relevance of the proposed
p.(None): research for CSC.
p.(None):
p.(None): 3. The NHQ External Research Review Committee will:
p.(None):
p.(None): a. review and assess research proposals and make recommendations to the EXCOM Sub-Committee for External Research
p.(None):
p.(None): b. consult with relevant NHQ sectors and regions implicated in proposed research as well as other departments and agencies that may be
p.(None): involved.
p.(None):
p.(None): 4. The Director, Research, will:
p.(None): a. coordinate the development and implementation of the Annual Research Plan and ensure its integrity
p.(None):
p.(None): b. establish a process to review research proposals (see Annex B), as required
p.(None):
p.(None): c. coordinate the dissemination of research results.
p.(None):
p.(None): 5. The regional research representatives will:
p.(None):
p.(None): a. review research proposals implicating their region
p.(None):
p.(None): b. share information and consult with implicated parties within the region, including the institutions, community residential facilities, and parole
p.(None): offices
p.(None):
p.(None): c. assess the feasibility of projects and give consideration to operational impacts and resource requirements.
p.(None):
p.(None): 6. The sites implicated will facilitate the researchers’ access to CSC facilities and provide support as outlined in the approved research proposal.
p.(None):
p.(None):
p.(None):
p.(None): Procedures
p.(None):
p.(None): Employee Opinion Survey
p.(None): 7. Employee opinion surveys may be considered public opinion research and are subject to the Policy on Communications and Federal Identity.
p.(None):
p.(None):
p.(None): Compensation for Participation
p.(None): 8. Inmates participating in research projects will not be compensated. Where participation requires an absence from a program assignment, those
p.(None): hours will be calculated as worked hours.
p.(None):
p.(None): 9. The NHQ External Research Review Committee will review and approve the provision of reasonable compensation for CSC employees and/or
p.(None): offenders under supervision participating in research project in the community.
p.(None):
p.(None):
p.(None): Medical Research and Experimental Treatment
p.(None): 10. Health-related research for external publication or dissemination is subject to the review and approval process outlined in this policy document.
p.(None):
p.(None): 11. There will be no experimental treatment unless it meets the necessary requirements of subsection 88(4) of the CCRA and section 115 of the CCRR,
p.(None): that provide for a review by a Treatment Demonstration Program Committee that is independent of CSC.
p.(None):
p.(None): 12. In accordance with section 115 of the CCRR, the Treatment Demonstration Program Committee shall be comprised of equal numbers from the
p.(None): community of lay persons and registered health care professionals with expertise related to the treatment demonstration program.
p.(None):
p.(None): 13. An offender may volunteer to participate in a medical research study or a treatment demonstration program, for which an ethics review has taken
p.(None): place, only if they:
p.(None):
p.(None): a. have been diagnosed as having a condition which the study addresses
p.(None):
...
General/Other / Public Emergency
Searching for indicator emergency:
(return to top)
p.(None):
p.(None): a. consent for disclosure from each participant is obtained
p.(None):
p.(None): b. the Commissioner determines that the information can be disclosed based upon the provisions of paragraph 8(2)(j) of the Privacy Act.
p.(None):
p.(None): 25. The Privacy Act provides the Research Branch the authority to access personal information and use administrative data without obtaining consent
p.(None): when it is to be used “for the purpose for which the information was obtained or compiled or for a use consistent with that purpose” (paragraph 7(a)),
p.(None): or “for research or statistical purposes if the head of government” is satisfied that subparagraphs 8(2)(j)(i) and/or (ii) are met.
p.(None):
p.(None): 26. There will be no subsequent disclosure of personal identifying information unless the participants have provided their consent or the information has
p.(None): been depersonalized in accordance with the undertaking given by the researcher under paragraph 8(2)(j) of the Privacy Act.
p.(None):
p.(None): 27. In the exceptional circumstance where the use of personal identifiers was unavoidable, the research will be reviewed and vetted by the NHQ
p.(None): Access to Information and Privacy Division
p.(None):
p.(None):
p.(None): Publication and Copyright
p.(None): 28. As per the Copyright Act, Her Majesty the Queen in Right of Canada, as represented by the Minister of Public Safety and Emergency
p.(None): Preparedness, is the owner of all intellectual property rights to the work prepared by CSC employees. This applies to all research conducted by
p.(None): employees as part of their official role and responsibilities.
p.(None):
p.(None): 29. In the case of research conducted without direction or control from CSC, the primary researcher owns the intellectual property rights to any thesis,
p.(None): journal articles, conference papers, or other written reports incorporating the results of a study approved by CSC. Any and all rights to materials
p.(None): and data used and provided by the primary researcher are the property of the primary researcher. Any and all rights to materials and data provided
p.(None): by CSC to the primary researcher are the property of CSC and will be returned to CSC at the end of the study.
p.(None):
p.(None): 30. In the case of research conducted under contract or otherwise sponsored by CSC (Memoranda of Understanding, Memoranda of Agreements, sole
p.(None): source contracts, etc.), the written undertaking must identify ownership of intellectual property and specify that all data is to be returned to CSC.
p.(None):
p.(None): 31. Copies of all reports resulting from approved research conducted by contractors, external researchers, or CSC employees shall be forwarded to the
p.(None): NHQ Research Branch for information purposes. Sufficient time (at least six weeks) must be given for their review in advance of any release,
...
General/Other / Relationship to Authority
Searching for indicator authority:
(return to top)
p.(None): institution, victims etc.
p.(None):
p.(None): 20. Approval to conduct research is effective the date the study is approved by CSC and will remain valid for a two year period following this date.
p.(None): Following this two year period, the researcher must request an extension or submit a new proposal.
p.(None):
p.(None): 21. Approval to conduct research may be temporarily suspended for operational reasons or may be withdrawn at any time for violations of standing
p.(None): orders, violations of rules and regulations related to security, and/or for unapproved deviations from the original proposal.
p.(None):
p.(None): 22. Data collected during a research study may only be used for the purposes outlined in the proposal; all subsequent or additional research questions
p.(None): must be submitted through the research proposal review and approval process.
p.(None):
p.(None):
p.(None): Personal Information
p.(None): 23. Researchers must obtain appropriate security clearance, in accordance with CD 564-1 – Individual Security Screening prior to receiving access to
p.(None): protected or personal identifying information.
p.(None):
p.(None): 24. Personal identifying information shall only be given to researchers if one of the two following conditions is met:
p.(None):
p.(None): a. consent for disclosure from each participant is obtained
p.(None):
p.(None): b. the Commissioner determines that the information can be disclosed based upon the provisions of paragraph 8(2)(j) of the Privacy Act.
p.(None):
p.(None): 25. The Privacy Act provides the Research Branch the authority to access personal information and use administrative data without obtaining consent
p.(None): when it is to be used “for the purpose for which the information was obtained or compiled or for a use consistent with that purpose” (paragraph 7(a)),
p.(None): or “for research or statistical purposes if the head of government” is satisfied that subparagraphs 8(2)(j)(i) and/or (ii) are met.
p.(None):
p.(None): 26. There will be no subsequent disclosure of personal identifying information unless the participants have provided their consent or the information has
p.(None): been depersonalized in accordance with the undertaking given by the researcher under paragraph 8(2)(j) of the Privacy Act.
p.(None):
p.(None): 27. In the exceptional circumstance where the use of personal identifiers was unavoidable, the research will be reviewed and vetted by the NHQ
p.(None): Access to Information and Privacy Division
p.(None):
p.(None):
p.(None): Publication and Copyright
p.(None): 28. As per the Copyright Act, Her Majesty the Queen in Right of Canada, as represented by the Minister of Public Safety and Emergency
p.(None): Preparedness, is the owner of all intellectual property rights to the work prepared by CSC employees. This applies to all research conducted by
p.(None): employees as part of their official role and responsibilities.
p.(None):
...
General/Other / tri-council policy statement
Searching for indicator tri-council:
(return to top)
p.(None): Health Service Assessment, Treatment and Release of Information.
p.(None):
p.(None): 14. The offender's involvement in a medical study or treatment demonstration program will be discontinued if requested by the researcher or the
p.(None): offender.
p.(None):
p.(None):
p.(None): Informed Consent
p.(None): 15. Where the research involves participants directly, each participant must give their informed and written consent prior to their involvement. The
p.(None): consent form will outline the objective of the study, the limits of confidentiality and any implications of participating in the research. It is the
p.(None): responsibility of the researchers to obtain this consent.
p.(None):
p.(None): 16. Informed consent for any type of research that involves treatment, including medical interventions, is defined in subsection 88(2) of the CCRA.
p.(None):
p.(None):
p.(None): Submission of Research Proposals
p.(None): 17. Researchers must complete the Research Application and Undertaking form (CSC/SCC 0954e) and supporting documents, where required, and
p.(None): submit them to NHQ Research Branch for review and approval.
p.(None):
p.(None): 18. Researchers affiliated with a university (including students and university staff) must obtain approval for proposed research projects from their
p.(None): respective university ethics committees prior to submitting a proposal to NHQ Research Branch. This review must be completed in compliance with
p.(None): the Tri-Council Policy Statement on Ethical Conduct for Research Involving Humans.
p.(None):
p.(None):
p.(None): Approval of Research Proposals
p.(None): 19. Research proposals will be assessed according to the following criteria:
p.(None): a. conformity with the principles of the CCRA and the Privacy Act
p.(None):
p.(None): b. contribution to the achievement of the Mission and the priorities of CSC
p.(None):
p.(None): c. compliance with the Tri-Council Policy Statement on Ethical Conduct for Research Involving Humans, including respect of the framework on
p.(None): ethical conduct of Research Involving the First Nations, Inuit and Métis Peoples of Canada
p.(None):
p.(None): d. level of disruption to operational units, including operational resources required during data collection
p.(None):
p.(None): e. quality of the methodology
p.(None):
p.(None): f. qualifications of researchers
p.(None):
p.(None): g. anticipated benefit to CSC
p.(None):
p.(None): h. level of risk, including but not limited to consideration of security threat risks, risks to the research team, offender and their family, staff,
p.(None): institution, victims etc.
p.(None):
p.(None): 20. Approval to conduct research is effective the date the study is approved by CSC and will remain valid for a two year period following this date.
p.(None): Following this two year period, the researcher must request an extension or submit a new proposal.
p.(None):
p.(None): 21. Approval to conduct research may be temporarily suspended for operational reasons or may be withdrawn at any time for violations of standing
p.(None): orders, violations of rules and regulations related to security, and/or for unapproved deviations from the original proposal.
p.(None):
p.(None): 22. Data collected during a research study may only be used for the purposes outlined in the proposal; all subsequent or additional research questions
p.(None): must be submitted through the research proposal review and approval process.
p.(None):
p.(None):
p.(None): Personal Information
...
p.(None): NHQ Research Branch for information purposes. Sufficient time (at least six weeks) must be given for their review in advance of any release,
p.(None): publication, presentation or other research dissemination.
p.(None):
p.(None): 32. Any research conducted by CSC employees and/or the use of an employee’s CSC affiliation in reporting independent research, including projects
p.(None): approved by the EXCOM Sub-Committee for External Research, must be submitted to the appropriate sector/regional heads for information
p.(None): purposes prior to external distribution. This includes but is not limited to publication in academic journals, conference presentations, book chapters,
p.(None): etc.
p.(None):
p.(None): 33. In the case of research conducted under contract or otherwise sponsored by the CSC Research Branch, sharing of research findings will be
p.(None): managed by the Director, Research.
p.(None):
p.(None): 34. Researchers will make appropriate acknowledgement in all reports of CSC’s sponsorship of the research, as well as an appropriate disclaimer that
p.(None): the opinions and conclusions do not necessarily represent those of the Service and/or Public Safety Canada.
p.(None):
p.(None):
p.(None): Commissioner,
p.(None):
p.(None):
p.(None):
p.(None): Original signed by:
p.(None): Don Head
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): Annex A
p.(None): Cross-References
p.(None): CD 564-1 – Individual Security Screening
p.(None): GL 800-3 – Consent to Health Service Assessment, Treatment and Release of Information
p.(None):
p.(None): Tri-Council Policy Statement on Ethical Conduct for Research Involving Humans
p.(None): Communications Policy of the Government of Canada
p.(None):
p.(None):
p.(None):
p.(None): Definitions
p.(None): EXCOM Sub-Committee for External Research: a committee comprised of the Senior Deputy Commissioner, the Assistant Commissioner, Policy, and
p.(None): the Director, Research Branch.
p.(None):
p.(None): NHQ External Research Review Committee: a committee comprised of the Director, Research Branch, Senior Research Managers, and
p.(None): representatives from the Correctional Operations and Programs Sector, Health Services, Women Offender Sector, and the Aboriginal Initiatives
p.(None): Directorate.
p.(None):
p.(None): Research: the systematic collection and use of data or the controlled investigation into a subject to provide an organized body of knowledge. The
p.(None): collection and/or analysis of CSC data that is required for administrative, operational or organizational purposes is not considered research. The objective
p.(None): of a research activity is to contribute to generalizable knowledge in the area of focus with the intent to share, distribute and/or disseminate findings when
p.(None): appropriate.
p.(None):
p.(None): Special Access Program: a program managed by Health Canada that has the mandate of making drugs that are not approved for use in Canada
p.(None): available on application by a practitioner. These drugs are used to treat patients with a serious or life-threatening illness when conventional therapies
p.(None): have failed or are unsuitable and may include pharmaceuticals, biological and radiopharmaceutical products.
p.(None):
...
Orphaned Trigger Words
p.(None):
p.(None):
p.(None): Medical Research and Experimental Treatment
p.(None): 10. Health-related research for external publication or dissemination is subject to the review and approval process outlined in this policy document.
p.(None):
p.(None): 11. There will be no experimental treatment unless it meets the necessary requirements of subsection 88(4) of the CCRA and section 115 of the CCRR,
p.(None): that provide for a review by a Treatment Demonstration Program Committee that is independent of CSC.
p.(None):
p.(None): 12. In accordance with section 115 of the CCRR, the Treatment Demonstration Program Committee shall be comprised of equal numbers from the
p.(None): community of lay persons and registered health care professionals with expertise related to the treatment demonstration program.
p.(None):
p.(None): 13. An offender may volunteer to participate in a medical research study or a treatment demonstration program, for which an ethics review has taken
p.(None): place, only if they:
p.(None):
p.(None): a. have been diagnosed as having a condition which the study addresses
p.(None):
p.(None): b. understand the objective of the study and the anticipated benefits and risks in comparison with the current best treatment or no treatment, as
p.(None): outlined by health care professionals who are registered or licensed in Canada
p.(None):
p.(None): c. understand and accept the methods to be used, including the use of controls, placebos, and randomization
p.(None):
p.(None): d. have signed a consent form which clearly describes the objective of the study, the offender’s understanding of their involvement and the
p.(None): implications of their consent. The requirements for this consent are in subsections 88(1), (2) and (3) of the CCRA and GL 800-3 – Consent to
p.(None): Health Service Assessment, Treatment and Release of Information.
p.(None):
p.(None): 14. The offender's involvement in a medical study or treatment demonstration program will be discontinued if requested by the researcher or the
p.(None): offender.
p.(None):
p.(None):
p.(None): Informed Consent
p.(None): 15. Where the research involves participants directly, each participant must give their informed and written consent prior to their involvement. The
p.(None): consent form will outline the objective of the study, the limits of confidentiality and any implications of participating in the research. It is the
p.(None): responsibility of the researchers to obtain this consent.
p.(None):
p.(None): 16. Informed consent for any type of research that involves treatment, including medical interventions, is defined in subsection 88(2) of the CCRA.
p.(None):
p.(None):
p.(None): Submission of Research Proposals
p.(None): 17. Researchers must complete the Research Application and Undertaking form (CSC/SCC 0954e) and supporting documents, where required, and
p.(None): submit them to NHQ Research Branch for review and approval.
p.(None):
p.(None): 18. Researchers affiliated with a university (including students and university staff) must obtain approval for proposed research projects from their
p.(None): respective university ethics committees prior to submitting a proposal to NHQ Research Branch. This review must be completed in compliance with
...
Appendix
Indicator List
Indicator | Vulnerability |
access | Access to Social Goods |
accessXtoXinformation | Access to information |
authority | Relationship to Authority |
emergency | Public Emergency |
employees | employees |
family | Motherhood/Family |
illness | Physically Disabled |
opinion | philosophical differences/differences of opinion |
property | Property Ownership |
threat | Threat of Stigma |
tri-council | tri-council policy statement |
volunteers | Healthy People |
women | Women |
Indicator Peers (Indicators in Same Vulnerability)
Trigger Words
consent
ethics
risk
volunteer
Applicable Type / Vulnerability / Indicator Overlay for this Input